Clinical pharmacology and pharmacotherapy: Problems and disputable issues


如何引用文章

全文:

详细

The paper discusses the current problems of internal medicine: the use of biologicals not only in rheumatology, but also in cardiology and pulmonology; current antiviral therapy for diseases of not only the liver, but also the heart (controversial issues); recent clinical data regarding LCZ (versus enalapril) and ivabradine (heart rate reduction).

作者简介

V Moiseev

Zh Kobalava

参考

  1. Юдин С.С. Воспоминания. М.: Издательский дом ТОНЧУ; 2012:688.
  2. Чазов Е.И. Здоровье и власть. М.: ГЭОТАР-Медиа; 2009:496.
  3. Генно-инженерные биологические препараты в лечении ревматоидного артрита. Под ред. Насонова Е.Л. М.: ИМА-Пресс; 2013:552.
  4. Hoofnagle J, Seeff L. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med. 2006;355:2444-2451.
  5. Bacon B, Gordon S, Lawitz E., Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R for the HCV RESPOND-2 Investigators Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1207-1217. doi: 10.1056/nejmoa1009482.
  6. Jacobson I, Mchutchison J, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S for the ADVANCE Study Team Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl JMed. 2011;364:2405. doi: 10.1056/nejmoa1012912.
  7. Cooper L, Knowlton K. Myocarditis. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1589-1602.
  8. Pankuveit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013;18:683-702. doi: 10.1007/s10741-012-9357-4.
  9. Gupalo EM, Buryachkovskaya LI, Golytsyn S, Balan M, Opavsky MA. Coxsackie-adenovirus receptor (CAR) in patients with cardiomyopathy of inflammatory and non-inflammatory etiology. Eur J Heart Fail. 2013;1(15):602. doi: 10.1016/j.yjmcc.2011.02.011.
  10. Покровский В.И., Пак С.Г., Брико Н.И. Данилкин Б.К. Инфекционные болезни и эпидемиология. Учебник. М.: ГЭОТАР-Медиа; 2004:295.
  11. Fisher S, Lipshultz S. Cardiovascular abnormalities in HIV-infected individuals. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1624-1635.
  12. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002.
  13. Hess OM, McKenna W, Schultheiss HP. Myocardial diseases. In: Camm AJ, Leischer TF, eds. The ESC Textbook of Cardiovascular Medicine. Serruys PW; Blackwell Publ., Ljuljana: Blackwell Publ; 2006:453-515.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Consilium Medicum, 2015

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##